Research Progress on the Treatment of Vascular Vertigo with Active Ingredients of Pueraria Lobata
DOI:
https://doi.org/10.53469/jcmp.2024.06(10).40Keywords:
Vascular dizziness, Pueraria lobata, Pharmacological mechanisms, SummarizeAbstract
Vascular vertigo is a common disease among middle-aged and elderly patients with vertigo, caused by cerebrovascular diseases, which seriously affects the quality of life of patients. Its pathogenesis is diverse, and there is still a lack of clear and effective therapeutic drugs in clinical practice. Pueraria lobata, as a commonly used traditional Chinese medicine for treating brain diseases, is widely used in clinical practice and has great development prospects. By summarizing the network pharmacology and clinical medication rules of vascular vertigo, it was found that Pueraria lobata is a high-frequency single traditional Chinese medicine for treating this disease. Modern pharmacological research has found that the main components of Pueraria lobata, such as isoflavones, triterpenes, coumarins, and alkaline compounds, can all play a preventive and therapeutic role in vascular dizziness. This article summarizes the published domestic and foreign papers and experiments, and takes the pathogenesis of vascular vertigo and the pharmacological characteristics of Pueraria lobata as a breakthrough point. Through sorting, it was found that Pueraria lobata exerts pharmacological effects in improving vascular endothelial function, regulating lipid metabolism, anticoagulation and antithrombotic effects, inhibiting oxidative stress, and regulating inflammatory reactions, and has significant effects on the clinical treatment of vascular vertigo.
References
Ling Xia, Wu Yuexia, Feng Yufei, etc. Vascular Vertigo and Dizziness: Diagnostic Criteria: Consensus Document of the Committeefor the Classification of Vestibular Disorders of theBárány Society [J]. Neurological Injury and Functional Reconstruction, 2023, 18 (12): 683-690.
Kim J S, Newman-Toker D E, Kerber K A, et al. Vascular vertigo and dizziness: Diagnostic criteria[J]. Journal of Vestibular Research, 2022, 32(3): 205-222.
Shao Liang, Guo Xiaoming, Cao Zhiyong, et al. Correlation between serum CML and plasma sCD40L levels and vascular vertigo in patients with atherosclerosis [J]. Journal of Brain and Nervous Diseases, 2022, 30 (1): 18-22.
Li Le, Xu Limei. Analysis of Prescription Medication Rules of Chinese Patent Medicine of Treating Diabetesin the 2020 edition of Chinese Pharmacopoeia Based on Data Mining [J]. Traditional Chinese Medicinal Research, 2023, 36(11):64-69.
Zheng Hao. Advances of Research And Development of Pueraria Radices[J]. Biotic Resources, 2019, 28(2): 24-26, 31.
HUANG Hui-zhong, XU Zi-jing, YANG Fan, et al. Review on chemical constituents, pharmacological effects and mechanism of Pueraria root[J]. Journal of Hubei University of Chinese Medicine, 2023, 26 (6):119-123.
Zhang Xue, Gao Qiong, Dong Qingji. High-dose kudzu treatment of cervical vertigo[J]. China's Naturopathy, 2020, 28 (13): 96-97.
LI Rui, HAO Xin-long, LIU Jun-chi, etc. Progress in the mechanism of improving cardiovascular disease by Pueraria puerariae and its active components[J]. Ginseng Research, 2021, 33(04): 59-61.
Bai T, Yu S, Feng J. Advances in the role of endothelial cells in cerebral small vessel disease[J]. Frontiers in neurology, 2022, 13: 861714.
GAO D, ZHANG X, HAN H, et al. Research advances in regulation of vascular smooth muscle cell phenotypes by vascular endothelial cells in arterial vascular diseases[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2024, 45(1): 100-104.
Deng Y, Ng E S K, Yeung J H K, et al. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery[J]. Journal of Ethnopharmacology, 2012, 139(1): 294-304.
Wang Henfei. The protective effect of puerarin on vascular endothelial injury caused by palmitic acid and high-fat diet[D]. Peking Union Medical College, 2022.
Deng Huafei, Li Jian, Zhou Qin, et al. Role of PI3K/Akt/eNOS signaling pathway in inhibitory effects of pue rarin on ox-LDL-induced TF expression in vascular endothelial cells[J]. Chinese Journal of Pathophysiology, 2017, 33(07): 1214-1218.
Li Huixin. Effects and mechanism of puerarin on intimlining of common carotid artery[D]. Journal of Shandong University of Traditional Chinese Medicine, 2023.
Ning Shangqiu, Wang Lvya, Wang Wei, et al. Effect of puerarin on PCNA and Suvivin in proliferating of vascular smooth muscle cell [J]. Journal of Cardiovascular and Pulmonary Diseases, 2010, 29(01): 56-60.
HU Yanwu, YANG Wenxin, BAO Xiaoxue, et al. Mechanisms of Puerarin in Improving Ameliorate Dyslipidemia and Inflammation in Atherosclerotic Rats[J]. Herald of Medicine 2021, 40(2): 5.
WANG Yuhong. Puerarin improves the disorder of glucose and lipid metabolism induced by olanzapine in rats through Sirt3/AMPK signal pathway[J]. Medical Science Journal of Central South China, 2022, 50(04): 513-516.
Hou Jiong, Zhang Tong, Li Lei, et al. Experimental study of PI3K / AKT / mTOR signaling regulation of hyperlipidemia in mice[J]. Lishizhen Medicine and Materia Medica Research, 2022.
Guo Ling, Wang Zhenhua, Huang Zjen. Study the effect of different dose of puerain on platelet surface factors such as GMP-140、Plasma TXB2 and 6-keto-PGF1α and their ratio changing in Type 2 diabetes[J]. Journal of China Prescription Drug, 2015, 13(11): 12-13.
Feng X, Li S W, Li H X, et al. Comparison of the anticoagulant, anti-platelet effects of puerarin injection and low molecular weight heparin sodium injection in vitro using Sonoclot [J]. Chin. J. Evid. Based. Cardiovasc. Med, 2017, 24: 183-186.
Chen Y U, Hua-Ying F. Anticoagulant Effect of Puerarin [J]. Lishizhen Medicine and Materia Medica Research 2011, 11:2663-2664.
Zhang Qianqian. Evaluation of the effect of puerarin in improving cerebral ischemia and reperfusion injury[D]. Anhui University of Traditional Chinese Medicine, 2023.
QIAO Wanning, CHEN Hongyin, ZHANG Yang. Oxidative stress and atherosclerosis[J]. Chinese Journal of Arteriosclerosis, 2023, 31(4): 312-321.
HUANG Jiapeng, ZHAO Jian, ZHAO Xuan, et al. Research Progress of Role of Nrf2 Signaling Pathway in Cognitive Dysfunction and Related Drugs[J]. Medical Recapitulate, 2022, 28(10): 1906-1910.
Tungmunnithum D, Intharuksa A, Sasaki Y. A Promising View of Kudzu Plant, Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep: Flavonoid phytochemical compounds, taxonomic data, traditional uses and potential biological activities for future cosmetic application[J]. Cosmetics, 2020, 7(1): 12.
CHEN Bo-xin, LIU Yi-nan, LI Hong-yan, et al. Neuroprotective effect of puerarin on ischemic brain injury in mice by antioxidant stress[J]. The Chinese Journal of Clinical Pharmacolog, 2021, 37(11): 1355-1362.
XU Jianguo, GU Ronghui, LI Shai, et al. Protective effect of soy isoflavones on rats after cerebral ischemia-reperfusion injury[J]. China Medicine And Pharmacy, 2023, 13(9): 30-3350
Zhang Q, Yao M, Qi J, et al. Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway[J]. Frontiers in Pharmacology, 2023, 14: 1134380.
ZHU Yunyan, ZHANG Chuanwu, CHEN Jing, et al. Research advances in the role and mechanism of distal ischemic preconditioning on inflammatory response in acute ischemic stroke[J]. Journal of Apoplexy and Nervous Diseases, 2024, 41(01): 35-40.
GAO Xing, LU Yanwan. Research advances in inflammatory response in patients with post-stroke cognitive impairment[J]. Journal of Apoplexy and Nervous Diseases, 2023, 40(07): 617-621.
Yang Li, He Shiyin. Effect of puerarin on inflammatory cytokine changes in cerebral ischemia after reperfusion in rats[J]. Chinese Journal of Gerontology, 2003, 23(3): 173-174
Zhou F, Wang L, Liu P, et al. Puerarin protects brain tissue against cerebral ischemia/reperfusion injury by inhibiting the inflammatory response[J]. Neural Regeneration Research, 2014, 9(23): 2074-2080.
Jeong JinWoo J J W, Lee HyeHyeon L H H, Han MinHo H M H, et al. Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia [J]. 2014.
Park J S, Woo M S, Kim D H, et al. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 320(3): 1237-1245.
Tracey K J. Physiology and immunology of the cholinergic antiinflammatory pathway[J]. The Journal of clinical investigation, 2007, 117(2): 289-296.
Bencherif M, Lippiello P M, Lucas R, et al. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases[J]. Cellular and molecular life sciences, 2011, 68: 931-949.
Liu X, Mei Z, Qian J, et al. Puerarin partly counteracts the inflammatory response after cerebral ischemia / reperfusion via activating the cholinergic anti-inflammatory pathway [J]. Neural regeneration research, 2013, 8(34): 3203-3215.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sha Wang, Lingli Gao, Ying Wang, Bing Xu
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
